Oral ciprofloxacin vs. Intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: Randomized prospective trial

Medical and Pediatric Oncology

Volumn 34, Issue 2, 2000, Pages 87-91

  Petrilli, Antonio Sérgio ^a   Dantas, Lenice Silva ^a   Campos, Mônica Cypiriano ^a   Tanaka, Cristiana ^a   Ginani, Valeria Cortez ^a   Seber, Adriana ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ceftriaxone; Ciprofloxacin; Fever; Infections; Neutropenia

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HOSPITAL INFECTION; HUMAN; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLID TUMOR;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AMBULATORY CARE; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; CEFTRIAXONE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; FEVER; HUMANS; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033952687     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(200002)34:2<87::AID-MPO2>3.0.CO;2-F     Document Type: Article

References (20)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966;64:328-340.
2. Pizzo PA, Robichaud KJ, Wesley RN, Commers JR. Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes. Medicine 1982;61:153-165.
3. Petrilli AS, Melaragno R, Barros KVT, et al. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Pediatr Infect Dis J 1993;12:916-921.
4. Lucas KG, Brown AE, Armstrong A, et al. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis. Cancer 1996;77:791-798.
5. Petrilli AS, Bianchi A, Kusano E, et al. Fever and granulocytopenia in children with cancer: a study of 299 episodes with two treatment protocols in Brazil. Med Pediatr Oncol 1993;21:356-361.
6. Charnas R, Lüthi AR, Ruch W (Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children). Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Pediatr Infect Dis J 1997; 16:346-353.
7. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993;119:584-593.
8. Petrilli SA, Melaragno R, Bianchi A, et al. Fever and neutropenia in pediatric oncology patients: new therapeutic proposition [in Portuguese]. AMB Rev Assoc Med Bras 1991;37:173-180.
9. Petrilli AS, Luisi F, Barros KVT, et al. Fever and neutropenia in oncology patients: outpatient therapy [in Portuguese]. J Pediatr 1993;69:213-220.
10. Mustafa MM, Aquino VM, Pappo A, et al. A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia. J Pediatr 1996;128:847-849.
11. Kaplinsky C, Drucker M, Goshen J, et al. Ambulatory treatment with ceftriaxone in febrile neutropenic children. Isr J Med Sci 1994;30:649-651.
12. Preis S, Jürgens H. Outpatient treatment with ceftriaxone alone or in combination with teicoplanin in febrile neutropenic children and adolescents with cancer. J Pediatr 1997;130:500-501.
13. Chysky V, Kapila K, Hullmann R, et al. Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation. Infection 1991;19:289-296.
14. Hampel B, Hullman R, Schmidt H. Ciprofloxacin in pediatrics: safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use - safety report. Pediatr Infect Dis J 1997;16:127-129.
15. Jick S. Ciprofloxacin safety in a pediatric population. Pediatr Infect Dis 1997;16:130-134.
16. Freifeld A, Pizzo P. Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients. Pediatr Infect Dis J 1997;16:140-146.
17. Lazarus HM, Creger RJ, Gerson SL. Infectious emergencies in oncology patients. Semin Oncol 1989;16:543-560.
18. Inagaki J, Rodriguez V, Bodey G. Causes of death in cancer patients. Cancer 1974;33:568-773.
19. Rubenstein E, Rolston R, Fingerg R, et al. Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer. Cancer 1993;71:3640-3646.
20. Warren RW. Rheumatologic aspects of pediatric cystic fibrosis patients treatment with fluoroquinolones. Pediatr Infect Dis J 1997;16:118-122.